The quality of reports of randomized trials in multiple sclerosis: a review

Multiple Sclerosis Journal, 04/24/2012

All of the methodological items indicated an improvement over time in the quality of reporting, the main weaknesses being frequent and inappropriate use of significance testing for assessing baseline imbalances and the statistical approach to subgroup analysis.

Print Article Summary Cat 2 CME Report